SK bioscience Co.,Ltd.

₩38,400As of Sun 8 Nov 2026, 12:00 UTC
KRX:302440Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (18.45%)
Div yield —
ROE (4.25%)
Biotechnology
Beta (5Y) 0.94
PE TTM —
TSR TTM (24.26%)
Mkt cap ₩2.997T
ROIC (7.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩46,456
20.98%
(86.43%)
Hold 10|6|6|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
595.43
623.92
654.95
725.78
27.76%
26.93%
32.86%
34.82%
Revenue₩B
159.6
163.1
162.5
168.8
1.38%
0.14%
(2.46%)
3.80%
Peers (US$2.209B)
Cap (US$)
PE
3.063B
—
1.673B
—
2.208B
—
Capital
TTM
5Y
10Y
Leveragex
0.509
0.282
0.281
EBIT/Intx
0.062
0.613
0.556
Own earn%
22.93
(83.24)
(75.62)
Sh yield%
15.06
34.58
36.21
Owners
Insiders/Inst%
4.96
88.02
Short interest%
3.51
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
12–20
$1 testx
0.0
Incr. ROIC%
2